BIG DATA & HEALTHCARE ANALYTICS: A HIMSS EVENT
BOSTON, Oct. 22-23, 2018
I. Glenn Cohen is Professor of Law at Harvard Law School, and Faculty Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. He also co-leads the the Law and Ethics Initiatives of the Football Players Health Study at Harvard University and the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst. His scholarship focuses on the intersection of bioethics and law, as well as health law. He also teaches civil procedure. Glenn’s current projects relate to reproductive technology, research ethics, rationing in law and medicine, health policy, and medical tourism. His past work has included projects on end-of-life decision making, FDA regulation, and commodification.
He recently released Patients with Passports: Medical Tourism, Law, and Ethics (Oxford University Press 2014) and The Globalization of Health Care: Legal and Ethical Issues (Oxford University Press 2013). He also has several co-edited volumes with Holly Fernandez Lynch, including Human Subjects Research Regulation: Perspectives on the Future (MIT Press 2014), and New and Enduring Challenges for FDA (under contract with Columbia University Press). Glenn and Holly co-edit the Petrie-Flom Center’s collaborative blog, Bill of Health. Prior to becoming a professor, Glenn served as a law clerk to Judge Michael Boudin of the U.S. Court of Appeals for the First Circuit and as a lawyer for U.S. Department of Justice, Civil Division, Appellate Staff, where he handled litigation in the Courts of Appeals and (in conjunction with the Solicitor General’s Office) in the U.S. Supreme Court. Glenn was selected as a Radcliffe Institute Fellow for the 2012-2013 year and by the Greenwall Foundation to receive a Faculty Scholar Award in Bioethics. He is one of three editors-in-chief of the Journal of Law and the Biosciences, a peer-reviewed journal published by Oxford University Press.
When data from all aspects of our lives can be relevant to our health - from our habits at the grocery store and our Google searches to our FitBit data and our medical records - can we really differentiate between big data and health big data?
Will health big data be used for good, such as to improve drug safety, or ill, as in insurance discrimination? Will it disrupt health care (and the health care system) as we know it? Will it be possible to protect our health privacy? What barriers will there be to collecting and utilizing health big data? What role should law play, and what ethical concerns may arise?
This timely, insightful presentation by one of the world’s leading experts on the intersection of bioethics and law, explores these questions and more from a variety of perspectives, examining how law promotes or discourages the use of big data in the health care sphere, and also what we can learn from other sectors.